Actively Recruiting
Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas
Led by University of Ulm · Updated on 2023-05-11
300
Participants Needed
1
Research Sites
1098 weeks
Total Duration
On this page
Sponsors
U
University of Ulm
Lead Sponsor
C
Charite University, Berlin, Germany
Collaborating Sponsor
AI-Summary
What this Trial Is About
The LoG-Glio-Registry is based on a network of german hospitals gathering radiological, clinical, epidemiological and molecular data on all patients diagnosed with a low grade glioma.
CONDITIONS
Official Title
Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with radiological suspected diagnosis of a low grade glioma
- Age 2618 years. There is no upper age limit.
You will not qualify if you...
- Severe neurological or psychiatric disorder interfering with ability to give an informed consent
- No consent for registration, storage and processing of the individual disease characteristics and course as well as information of the family physician about study participation
- No consent for bio-banking of patient's biological specimens and performance of analyses on stored material.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Ulm
Ulm, Germany
Actively Recruiting
Research Team
J
Jan Coburge, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here